|
|
|
Insider
Information: |
Mueller Peter |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
311,837 |
|
Indirect Shares
|
25,571 |
|
|
Direct
Value |
$67,267,974 |
|
|
Indirect Value
|
$11,948,817 |
|
|
Total
Shares |
337,408 |
|
|
Total
Value |
$79,216,791 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Global R&D, CSO |
2014-06-16 |
143,517 |
2014-06-16 |
25,571 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Bioxcel Therapeutics Inc |
BTAI |
Director |
2019-08-23 |
168,320 |
2018-12-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-07-15 |
4 |
OE |
$10.41 |
$26,025 |
D/D |
2,500 |
136,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-08-29 |
4 |
OE |
$10.41 |
$103,367 |
D/D |
9,500 |
143,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-09-15 |
4 |
OE |
$11.27 |
$107,065 |
D/D |
9,500 |
143,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-05-07 |
4 |
OE |
$11.27 |
$1,346,025 |
D/D |
79,500 |
227,736 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO&EVP Drug Innov&Realization |
|
2006-11-16 |
4 |
OE |
$16.32 |
$288,636 |
D/D |
17,686 |
102,912 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-04-25 |
4 |
OE |
$16.32 |
$204,000 |
D/D |
12,500 |
146,235 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-06-15 |
4 |
OE |
$16.32 |
$106,080 |
D/D |
6,500 |
138,816 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-07-16 |
4 |
OE |
$16.32 |
$106,080 |
D/D |
6,500 |
138,816 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-08-15 |
4 |
OE |
$16.32 |
$106,080 |
D/D |
6,500 |
138,816 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-09-17 |
4 |
OE |
$16.32 |
$106,080 |
D/D |
6,500 |
138,816 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2012-10-15 |
4 |
OE |
$16.32 |
$106,080 |
D/D |
6,500 |
138,816 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-07-02 |
4 |
OE |
$16.32 |
$3,766,911 |
D/D |
122,300 |
266,700 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2011-09-20 |
4 |
OE |
$17.16 |
$441,390 |
D/D |
25,000 |
158,735 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-07-15 |
4 |
OE |
$18.93 |
$141,975 |
D/D |
7,500 |
151,900 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-08-15 |
4 |
OE |
$18.93 |
$141,975 |
D/D |
7,500 |
151,900 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-09-16 |
4 |
OE |
$18.93 |
$141,975 |
D/D |
7,500 |
151,900 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-10-15 |
4 |
OE |
$18.93 |
$141,975 |
D/D |
7,500 |
151,900 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
|
2013-11-15 |
4 |
OE |
$18.93 |
$186,570 |
D/D |
7,500 |
151,900 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2008-10-15 |
4 |
AS |
$25.73 |
$64,049 |
D/D |
(2,400) |
86,390 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2008-12-15 |
4 |
AS |
$25.81 |
$61,944 |
D/D |
(2,400) |
86,390 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2009-04-15 |
4 |
AS |
$26.98 |
$64,752 |
D/D |
(2,400) |
129,670 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2008-05-13 |
4 |
AS |
$27.00 |
$41,794 |
D/D |
(1,541) |
86,390 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2008-11-17 |
4 |
AS |
$27.14 |
$65,136 |
D/D |
(2,400) |
86,390 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CSO & SVP Drug Discovery |
|
2005-12-21 |
4 |
AS |
$27.84 |
$41,649 |
D/D |
(1,496) |
74,554 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP Drug Innov.& Realiz, CSO |
|
2008-09-17 |
4 |
AS |
$27.94 |
$67,056 |
D/D |
(2,400) |
86,390 |
0 |
- |
|
141 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|